Companies:
53,025
Total Market Cap:
169002833548104.08
Etropal AD's latest marketcap:
12.1 M
As of 04/30/2026, Etropal AD's market capitalization has reached $12.1 M. According to our data, Etropal AD is the 41329th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 12.1 M |
| Revenue (ttm) | 12.16 M |
| Net Income (ttm) | 194,617.97 |
| Shares Out | 5 M |
| EPS (ttm) | 0.04 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/29/2026 |
Market Cap Chart
Data Updated: 04/30/2026
Etropal AD's yearly market capitalization.
Etropal AD has seen its market value drop from 28.75 M BGN to 22.27 M BGN since 2020, representing a total decrease of 22.53% and an annual compound decline rate (CAGR) of 4.60%.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 05/27/2026 | 22.27 M | $0 | -1.01% | n/a |
| 12/22/2025 | 22.5 M | $13.36 M | 4.65% | n/a |
| 12/17/2024 | 21.5 M | $11.41 M | -6.52% | n/a |
| 12/21/2023 | 23 M | $12.98 M | -25.81% | n/a |
| 12/30/2022 | 31 M | $16.89 M | 7.83% | n/a |
| 12/21/2021 | 28.75 M | $16.63 M | 0% | n/a |
| 12/23/2020 | 28.75 M | $0 | n/a |
Company Profile
Etropal AD engages in the development, manufacture, and sale of disposable medical devices for dialysis in Bulgaria.
The company offers capillary dialyzers; arterial-venous blood line sets; procedure kits; and arterial-venous fistula needles.
Etropal AD was founded in 1976 and is headquartered in Etropole, Bulgaria. Etropal AD is a subsidiary of Synthetica AD.
Frequently Asked Questions
-
What is Etropal AD's (BUL-ETR) current market cap?As of 04/30/2026, Etropal AD (including the parent company, if applicable) has an estimated market capitalization of $12.1 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Etropal AD (BUL-ETR) rank globally by market cap?Etropal AD global market capitalization ranking is approximately 41329 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.